Want to join the conversation?
Life science products company $STE said 4Q16 revenue increased 38% driven by the acquisition of Synergy Health, Black Diamond Video and GEPCO in addition to solid organic revenue growth. Constant currency organic revenue growth was 5% and was driven entirely by volume as price was neutral during the qtr. FX negatively impacted revenue by 1%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?